Persons with dispensed medicines; background; 2006-2020

Changed on: 15/12/2022 02:00

Persons with dispensed medicines; background; 2006-2020
Sex	Age	Background and generation	Medicine group (ATC)	Periods	Persons with medicines, relative (%)
Total male and female	0 to 64 years, standardised	Total background and generation	Total	2020	56.54
Total male and female	0 to 64 years, standardised	Total background and generation	A10 Drugs used in diabetes	2020	2.36
Total male and female	0 to 64 years, standardised	Total background and generation	J01 Antibacterials for systemic use	2020	13.90
Total male and female	0 to 64 years, standardised	Total background and generation	N02C Antimigraine preparations	2020	1.38
Total male and female	0 to 64 years, standardised	Total background and generation	N06A Antidepressants	2020	5.03
Total male and female	0 to 64 years, standardised	Total background and generation	R03 Drugs for obstruct. airway diseases	2020	6.70
Total male and female	0 to 64 years, standardised	Dutch background	Total	2020	57.58
Total male and female	0 to 64 years, standardised	Dutch background	A10 Drugs used in diabetes	2020	1.99
Total male and female	0 to 64 years, standardised	Dutch background	J01 Antibacterials for systemic use	2020	14.06
Total male and female	0 to 64 years, standardised	Dutch background	N02C Antimigraine preparations	2020	1.51
Total male and female	0 to 64 years, standardised	Dutch background	N06A Antidepressants	2020	5.23
Total male and female	0 to 64 years, standardised	Dutch background	R03 Drugs for obstruct. airway diseases	2020	6.84
Total male and female	0 to 64 years, standardised	With migration background	Total	2020	54.39
Total male and female	0 to 64 years, standardised	With migration background	A10 Drugs used in diabetes	2020	3.76
Total male and female	0 to 64 years, standardised	With migration background	J01 Antibacterials for systemic use	2020	13.54
Total male and female	0 to 64 years, standardised	With migration background	N02C Antimigraine preparations	2020	1.06
Total male and female	0 to 64 years, standardised	With migration background	N06A Antidepressants	2020	4.63
Total male and female	0 to 64 years, standardised	With migration background	R03 Drugs for obstruct. airway diseases	2020	6.47
Total male and female	0 to 64 years, standardised	1st generation migration background	Total	2020	47.77
Total male and female	0 to 64 years, standardised	1st generation migration background	A10 Drugs used in diabetes	2020	4.24
Total male and female	0 to 64 years, standardised	1st generation migration background	J01 Antibacterials for systemic use	2020	12.08
Total male and female	0 to 64 years, standardised	1st generation migration background	N02C Antimigraine preparations	2020	0.92
Total male and female	0 to 64 years, standardised	1st generation migration background	N06A Antidepressants	2020	4.51
Total male and female	0 to 64 years, standardised	1st generation migration background	R03 Drugs for obstruct. airway diseases	2020	5.11
Total male and female	0 to 64 years, standardised	2nd generation migration background	Total	2020	59.47
Total male and female	0 to 64 years, standardised	2nd generation migration background	A10 Drugs used in diabetes	2020	2.43
Total male and female	0 to 64 years, standardised	2nd generation migration background	J01 Antibacterials for systemic use	2020	14.66
Total male and female	0 to 64 years, standardised	2nd generation migration background	N02C Antimigraine preparations	2020	1.30
Total male and female	0 to 64 years, standardised	2nd generation migration background	N06A Antidepressants	2020	4.72
Total male and female	0 to 64 years, standardised	2nd generation migration background	R03 Drugs for obstruct. airway diseases	2020	7.91
Total male and female	0 to 64 years, standardised	Western migration background	Total	2020	47.03
Total male and female	0 to 64 years, standardised	Western migration background	A10 Drugs used in diabetes	2020	2.01
Total male and female	0 to 64 years, standardised	Western migration background	J01 Antibacterials for systemic use	2020	11.86
Total male and female	0 to 64 years, standardised	Western migration background	N02C Antimigraine preparations	2020	1.03
Total male and female	0 to 64 years, standardised	Western migration background	N06A Antidepressants	2020	4.05
Total male and female	0 to 64 years, standardised	Western migration background	R03 Drugs for obstruct. airway diseases	2020	5.54
Total male and female	0 to 64 years, standardised	Non-western migration background	Total	2020	59.75
Total male and female	0 to 64 years, standardised	Non-western migration background	A10 Drugs used in diabetes	2020	5.35
Total male and female	0 to 64 years, standardised	Non-western migration background	J01 Antibacterials for systemic use	2020	14.80
Total male and female	0 to 64 years, standardised	Non-western migration background	N02C Antimigraine preparations	2020	1.07
Total male and female	0 to 64 years, standardised	Non-western migration background	N06A Antidepressants	2020	5.15
Total male and female	0 to 64 years, standardised	Non-western migration background	R03 Drugs for obstruct. airway diseases	2020	7.13
Total male and female	0 to 64 years, standardised	Morocco	Total	2020	65.33
Total male and female	0 to 64 years, standardised	Morocco	A10 Drugs used in diabetes	2020	7.09
Total male and female	0 to 64 years, standardised	Morocco	J01 Antibacterials for systemic use	2020	16.66
Total male and female	0 to 64 years, standardised	Morocco	N02C Antimigraine preparations	2020	1.19
Total male and female	0 to 64 years, standardised	Morocco	N06A Antidepressants	2020	7.26
Total male and female	0 to 64 years, standardised	Morocco	R03 Drugs for obstruct. airway diseases	2020	8.41
Total male and female	0 to 64 years, standardised	Turkey	Total	2020	65.40
Total male and female	0 to 64 years, standardised	Turkey	A10 Drugs used in diabetes	2020	5.95
Total male and female	0 to 64 years, standardised	Turkey	J01 Antibacterials for systemic use	2020	18.38
Total male and female	0 to 64 years, standardised	Turkey	N02C Antimigraine preparations	2020	1.48
Total male and female	0 to 64 years, standardised	Turkey	N06A Antidepressants	2020	8.64
Total male and female	0 to 64 years, standardised	Turkey	R03 Drugs for obstruct. airway diseases	2020	8.31
Total male and female	0 to 64 years, standardised	Surinam	Total	2020	63.88
Total male and female	0 to 64 years, standardised	Surinam	A10 Drugs used in diabetes	2020	6.15
Total male and female	0 to 64 years, standardised	Surinam	J01 Antibacterials for systemic use	2020	14.20
Total male and female	0 to 64 years, standardised	Surinam	N02C Antimigraine preparations	2020	1.02
Total male and female	0 to 64 years, standardised	Surinam	N06A Antidepressants	2020	3.63
Total male and female	0 to 64 years, standardised	Surinam	R03 Drugs for obstruct. airway diseases	2020	8.70
Total male and female	0 to 64 years, standardised	(former) Net Antilles, Aruba	Total	2020	59.25
Total male and female	0 to 64 years, standardised	(former) Net Antilles, Aruba	A10 Drugs used in diabetes	2020	4.01
Total male and female	0 to 64 years, standardised	(former) Net Antilles, Aruba	J01 Antibacterials for systemic use	2020	14.15
Total male and female	0 to 64 years, standardised	(former) Net Antilles, Aruba	N02C Antimigraine preparations	2020	1.12
Total male and female	0 to 64 years, standardised	(former) Net Antilles, Aruba	N06A Antidepressants	2020	3.22
Total male and female	0 to 64 years, standardised	(former) Net Antilles, Aruba	R03 Drugs for obstruct. airway diseases	2020	8.06
Total male and female	0 to 64 years, standardised	Other non-western background	Total	2020	54.46
Total male and female	0 to 64 years, standardised	Other non-western background	A10 Drugs used in diabetes	2020	4.25
Total male and female	0 to 64 years, standardised	Other non-western background	J01 Antibacterials for systemic use	2020	13.03
Total male and female	0 to 64 years, standardised	Other non-western background	N02C Antimigraine preparations	2020	0.88
Total male and female	0 to 64 years, standardised	Other non-western background	N06A Antidepressants	2020	3.75
Total male and female	0 to 64 years, standardised	Other non-western background	R03 Drugs for obstruct. airway diseases	2020	5.48
Source: CBS.

Explanation of symbols

Table explanation

This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
CBS is switching to a new population classification by origin. Greater emphasis will be placed on where a person was born and less on where their parents were born. The term ‘migration background’ will no longer be used in this regard. The main categories western/non-western will be replaced by categories based on continents and a few countries that share a specific migration history with the Netherlands. This classification will gradually been introduced in tables and publications with population by origin.

Data are broken down by medicine group, background, generation, age and sex.

Data available from 2006 to 2020.

Status of the figures:
All figures are definite.

Changes as of 14 December, 2022:
Figures for 2020 have been made final without change and the table has been stopped due to the introduction of the new classification of population by origin.

When will new figures be published?
Not applicable, the table has been stopped. This table will be replaced by the new table 'Persons with dispensed medicines; origin', see chapter 3.

Description topics

Persons with medicines, relative: Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.